Nyxoah S.A.

Status: Publicly traded

Direct answer

Nyxoah S.A. is publicly traded on NASDAQ under the ticker NYXH.

Nyxoah S.A. is a medical technology company dedicated to developing and bringing to market therapies for sleep disordered breathing conditions. Its flagship offering is the Genio system, a CE-Marked, patient-focused hypoglossal neurostimulation therapy that addresses moderate to severe obstructive sleep apnea. Established in 2009, the company maintains its headquarters in Mont-Saint-Guibert, Belgium.

Can you invest in Nyxoah S.A.?

Yes. Nyxoah S.A. trades publicly on NASDAQ as NYXH.

View deeper analysis

View detailed research on MarketSnap, including financials, valuation tools, and analyst context.

Open research for Nyxoah S.A.

Detailed equity research is provided by MarketSnap.